Gensia Pharmaceuticals Inc., Marion Merrell Dow Inc. deal

MMD decided not to exercise its option on GNSA's adenosine compound GP-1-531 for cardiovascular use. MMD spokesperson Charles

Read the full 182 word article

How to gain access

Continue reading with a
two-week free trial.